Publications in the NUM
Here you will find a list of publications that were written in connection with the Network of University Medicine in the first and second funding phases.
Groß R,
et al .
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
EBioMedicine.
2021;
75103761.
[DOI]
Tenbusch M,
Schumacher S,
Vogel E,
et al .
Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2.
Lancet Infect Dis.
2021;
21(9):
[DOI]
Rössler M,
Jacob J,
Risch L,
Tesch F,
Enders D,
Wende D,
Jucknewitz R,
Weidinger O,
Batram M,
Ballesteros P,
Baßler S,
Hertle D,
Repschläger U,
Richter N,
Schulte C,
Schramm A,
Sobik F,
Treskova-Schwarzbach M,
Scholz S,
Walker J,
others .
Hierarchisierung von Risikofaktoren für schwere COVID-19-Erkrankungsverläufe im Kontext der COVID-19-Schutzimpfungen.
2021;
[DOI]
Lehmann M,
Allers K,
Heldt C,
Meinhardt J,
Schmidt F,
Rodriguez-Sillke ea.
Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8(+) T cells.
Mucosal Immunol.
2021;
141381—1392.
Lehmann M,
Allers K,
Heldt C,
et al .
Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells.
Mucosal Immunol.
2021;
1-12.
[DOI]
Trump S,
Lukassen S,
Anker SM,
Chua RL,
Liebig J,
Thurmann ea.
Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19.
Nat Biotechnol.
2021;
39705—716.
[DOI]
Walsh C,
Tafforeau P,
Wagner W,
et al .
Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography.
Nat Methods.
2021;
18(12):1532-1541.
[DOI]
Barros-Martins J,
et al .
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.
Nature Medicine.
2021;
271525—1529.
[DOI]
Burnett DL,
et al .
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability.
Immunity.
2021;
542908—2921.e6.
[DOI]
Schrezenmeier E,
et al .
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Frontiers in immunology.
2021;
12690698.
[DOI]
Ahrens KF,
Neumann RJ,
Kollmann B,
Brokelmann J,
Werthern NM,
Malsyhau A,
Weichert D,
Lutz B,
Fiebach CJ,
Wessa M,
others .
Impact of COVID-19 lockdown on mental health in Germany: Longitudinal observation of different mental health trajectories and protective factors.
Translational Psychiatry.
2021;
11(1):1—10.
[DOI]
Mühlemann B,
et al .
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalised COVID-19 patients - results from a prospective observational study.
Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
2021;
[DOI]
Mühlemann B,
Thibeault C,
Hillus D,
Helbig E,
Lippert L,
Tober-Lau P,
Schwarz T,
Müller M,
group P,
Witzenrath M,
others .
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study.
Clin Microbiol Infect.
2021;
[DOI]
Ricke-Hoch M,
Stelling E,
Lasswitz L,
Gunesch A,
Kasten M,
Zapatero-Belinchón F,
Brogden G,
Gerold G,
Pietschmann T,
Montiel V,
Balligand J,
Facciotti F,
Hirsch E,
Gausepohl T,
Elbahesh H,
Rimmelzwaan G,
Höfer A,
Kühnel M,
Jonigk D,
Eigendorf J,
Tegtbur U,
Mink L,
Scherr M,
Illig T,
Schambach A,
Pfeffer T,
Hilfiker A,
Haverich A,
Hilfiker-Kleiner D.
Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease.
PLoS One.
2021 Aug.;
16(8):e0255335.
[DOI]
Dauletbaev N,
Kuhn S,
Holtz S,
Waldmann S,
Niekrenz L,
Müller BS,
Bellinghausen C,
Dreher M,
Rohde GGU,
Vogelmeier C.
Implementation and use of mHealth home telemonitoring in adults with acute COVID-19 infection: A scoping review protocol.
BMJ Open.
2021;
11(9):e053819.
[DOI]
Müller A,
Melzow FS,
Göstemeyer G,
Paris S,
Schwendicke F.
Implementation of COVID-19 Infection Control Measures by German Dentists: A Qualitative Study to Identify Enablers and Barriers.
International Journal of Environmental Research and Public Health.
2021;
18(11):5710.
[DOI]
Hennig V,
et al .
Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia.
Orphanet Journal of Rare Diseases.
2021;
16373.
[DOI]
Weiner J,
Suwalski P,
Holtgrewe M,
Rakitko A,
Thibeault C,
Müller M,
Patriki D,
Quedenau C,
Krüger U,
Ilinsky V,
others .
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01.
EClinicalMedicine.
2021;
[DOI]
Dickel S,
Grimm C,
Popp M,
Struwe C,
Sachkova A,
Golinski M,
Seeber C,
Fichtner F,
Heise D,
Kranke P,
Meissner W,
Laudi S,
Voigt-Radloff S,
Meerpohl J,
Jabs J,
Mutters N,
Moerer O,
Group On Behalf Of The German CEOsys Study .
Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.
GMS Hyg Infect Control.
2021;
16Doc21.
[DOI]
Köster A,
Bludau A,
Devcic S,
et al .
Infection surveillance measures during the COVID-19 pandemic in Germany.
GMS Hyg Infect Control.
2021;
16
[DOI]
Köster AM,
Bludau A,
Devcic SK,
Scheithauer S,
Mardiko AA,
Schaumann R.
Infection surveillance measures during the COVID-19 pandemic in Germany.
GMS hygiene and infection control.
2021;
16Doc27.
[DOI]
Wyler E,
Adler JM,
Eschke K,
Alves GT,
Peidli S,
Pott ea.
Insights into standards of care – dexamethasone and antibodies against COVID-19 in hamster models.
bioRxiv.
2021;
[DOI]
Houwaart T,
Belhaj S,
Tawalbeh E,
et al .
Integrated Genomic Surveillance reveals extensive onward transmission of travel-imported SARS-CoV-2 infections in the community.
MedRxiv.
2021;
[DOI]
Schroeder S,
Pott F,
Niemeyer D,
Veith T,
Richter A,
Muth ea.
Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics.
Lancet Microbe.
2021;
2e210—e218.
[DOI]
Burns J,
Movsisyan A,
Stratil J,
Biallis R,
Coenen M,
Emmert-Fees K,
Geffert K,
Hoffmann S,
Horstick O,
Laxy M,
Klinger C,
Kratzer S,
Litwin T,
Norris S,
Pfadenhauer L,
Philipsborn P,
Sell K,
Stadelmaier B,
Voss S,
Wabnitz K,
Rehfuess E.
International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
Cochrane Database of Systematic Reviews.
2021;
3
[DOI]
Strobl S,
Roth W.
Internationale wissenschaftliche Publikationsaktivität zu COVID-19 [International publication activity during the COVID-19 pandemic].
Pathologe.
2021;
42(2):224-230.
Andreas M,
Piechotta V,
Skoetz N,
Grummich K,
Becker M,
Joos L,
Becker G,
Meissner W,
Boehlke C.
Interventions for palliative symptom control in COVID-19 patients.
Cochrane Database of Systematic Reviews.
2021;
2021(8):CD015061.
[DOI]
Andreas M,
Piechotta V,
Skoetz N,
Grummich K,
Becker M,
Joos S,
Becker G,
Meissner W,
Boehlke C.
Interventions for palliative symptom control in COVID-19 patients.
Cochrane Database of Systematic Reviews.
2021;
CD015061.
[DOI]
Halwe S,
et al .
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.
Viruses.
2021;
13
[DOI]
Bošnjak B,
et al .
Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents.
Frontiers in Immunology.
2021;
12772240.
[DOI]
Popp M,
Stegemann M,
Metzendorf M,
Gould S,
Kranke P,
Meybohm P,
Skoetz N,
Weibel S.
Ivermectin for preventing and treating COVID‐19.
Cochrane Database of Systematic Reviews.
2021;
2021CD015017.
[DOI]
Malin JJ,
Spinner CD,
Janssens U,
Welte T,
Weber-Carstens S,
Schälte G,
Gastmeier P,
Langer F,
Wepler M,
Westhoff M,
Pfeifer M,
Rabe KF,
Hoffmann F,
Böttiger BW,
Weinmann-Menke J,
Kersten A,
Berlit P,
Krawczyk M,
Nehls W,
Fichtner F,
Laudi S,
Stegemann M,
Skoetz N,
Nothacker M,
Marx G,
Karagiannidis C,
Kluge S.
Key summary of German national treatment guidance for hospitalized COVID-19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).
Infection.
2021;
[DOI]
Vanshylla K,
et al .
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans.
Cell host & microbe.
2021;
[DOI]
Schmidt M,
Löwe C,
Kugai S,
Thielmann A,
Weltermann B.
Kommunikations- und Kooperationsstrukturen von Hausärzt*innen und Gesundheitsämtern – Erkenntnisse der egePan-Studie.
DocV-22-02.
2021;
[DOI]
Stillfried S,
Acker T,
Aepfelbacher M,
Baretton G,
Bülow RD,
Bürrig KF,
Holtherm UH,
Jonigk D,
Knüchel R,
Majeed RW,
Röhrig R,
Wienströer J,
Boor P.
Kooperatives Vorgehen der Pathologie und Neuropathologie in der COVID-19-Pandemie : Deutsches Register für COVID-19-Obduktionen (DeRegCOVID) und Deutsches Netzwerk für Autopsien in Pandemien (DEFEAT PANDEMIcs) [Cooperative approach of pathology and neuropathology in the COVID-19 pandemic : German registry for COVID-19 autopsies (DeRegCOVID) and German network for autopsies in pandemics (DEFEAT PANDEMIcs)].
Pathologe.
2021;
42(2):216-223.
Englisch CN,
Tschernig T,
Flockerzi F,
Meier C,
Bohle RM.
Lesions in the lungs of fatal coronavirus disease COVID-19.
Ann Anat.
2021;
234151657.
[DOI]
Theobald SJ,
et al .
Long-lived macrophage reprogramming drives spike protein–mediated inflammasome activation in COVID–19.
EMBO Mol Med.
2021;
[DOI]
Knolle P,
Körber N,
Priller A,
et al .
Long-term follow-up of SARS-CoV-2 convalescents reveals distinct magnitude of spike-specific immunity after viral re-exposure and vaccination.
Research Square.
2021;
[DOI]
Horn A,
Krist L,
Lieb W,
Montellano F,
Kohls M,
Haas K,
Gelbrich G,
Bolay-Gehrig S,
Morbach C,
Reese J,
others .
Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).
Infection.
2021;
49(6):1277—1287.
[DOI]
Tober-Lau P,
et al .
Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers.
The Lancet Respiratory Medicine.
2021;
9e104-e105.
[DOI]
Jan\'ıková M,
Hodosy J,
Boor P,
Klempa B,
Celec P.
Loop-mediated isothermal amplification for the detection of SARS-CoV-2 in saliva.
Microb Biotechnol.
2021;
14(1):307-316.
[DOI]
Contreras S,
Dehning J,
Mohr SB,
Bauer S,
Spitzner FP,
Priesemann V.
Low case numbers enable long-term stable pandemic control without lockdowns.
Science advances.
2021;
7(41):eabg2243.
[DOI]
Kuhlmann E,
Heinemann S,
Bludau A,
et al .
Managing protection and surveillance of health workers during COVID-19: German multi-centre survey.
Eur J Public Health.
2021;
31(Supplement 3):
[DOI]
Holfelder M,
et al .
Medical Device Regulation Efforts for mHealth Apps during the COVID-19 Pandemic—An Experience Report of Corona Check and Corona Health.
J.
2021;
4206—222.
[DOI]
Bartels C,
Hessmann P,
Schmidt U,
Vogelgsang J,
Ruhleder M,
Kratzenberg A,
Treptow M,
Reh-Bergen T,
Abdel-Hamid M,
Heß L,
Meiser M,
Signerski-Krieger J,
Radenbach K,
Trost S,
Schott BH,
Wiltfang J,
Wolff-Menzler C,
Belz M.
Medium-term and peri-lockdown course of psychosocial burden during the ongoing COVID-19 pandemic: A longitudinal study on patients with pre-existing mental disorders.
European Archives of Psychiatry and Clinical Neuroscience.
2021;
[DOI]
Stiel S,
Schneider N.
Mehr Nähe am Lebensende trotz Pandemie ermöglichen – MHH untersucht im Forschungsverbund PallPan Auswirkungen auf ambulante Palliativversorgung.
MHH Insight.
2021;
[DOI]